2010 ART guidelines for adults and adolescents - evidence map
The 2010 revision of WHO Antiretroviral therapy for HIV infection in adults and adolescents, was based on a process of review and synthesis of new and emerging evidence. This process included consideration of systematic reviews, GRADE profiles, risk-benefit analyses, technical reports, as well as the findings from impact, feasibility and cost assessments, each contributing to the development of sound global recommendations.
These guidelines have been developed for a global audience and it is expected that to be effectively implemented, each country will adapt them to their local context.
To assist countries to adapt these new recommendations, all the evidence materials used in their creation are now available on the WHO website for use by programme managers, academic institutions and national ART advisory committees in updating guidelines for adults and adolescents according to their local circumstances.
- Rapid advice: Antiretroviral therapy for HIV Infection in adults and adolescents
-
Meeting report: revision of WHO ART guidelines for adults and adolescents
pdf, 361kb
Selected presentations
-
Summary of rapid advice on ART for HIV+ adults and adolescents
pdf, 104kb -
ART recommendations at a glance
pdf, 34kb -
ART guidelines development process
pdf, 540kb
Evaluating evidence using GRADE methodology: selected articles
Summary of evidence, GRADE tables and risk-benefit analysis
When to start ART in HIV+ adults and adolescents
GRADE table
What to start in HIV+ adults and adolescents
GRADE tables
-
AZT versus d4T for initial ART
pdf, 56kb -
TDF versus AZT or d4T for initial ART
pdf, 42kb -
TDF versus ABC for initial ART
pdf, 59kb -
EFV versus NVP for initial ART
pdf, 32kb
Risk-benefit analysis
ART in specific populations
TB/HIV co-infection
GRADE tables
-
Integrated versus sequential initiation of ART in HIV+ people co infected with TB
pdf, 24kb -
EFV versus NVP in initial ART for HIV+ people co-infected with TB
pdf, 36kb
HIV/HBV co-infection
GRADE tables
-
Early versus deferred ART initiation in HBV/HIV co infection
pdf, 26kb -
TDF+3TC or FTC versus 3TC (or FTC) in 1st line ART regimens for HBV/HIV co infection
pdf, 73kb -
TDF+3TC (or FTC) versus 3TC (or FTC) in 2nd line ART regimens for HBV/HIV co infection
pdf, 29kb
-
Risk-benefit analysis: ART in HBV/HIV co-infection
pdf, 55kb -
Scoping document: a review of viral hepatitis in injecting drug users and assessment of priorities for future activities
pdf, 1.05Mb
HIV+ pregnant women
-
Recommendations
pdf, 33kb -
GRADE table: AZT+3TC+NVP versus AZT (+sd NVP) for HIV+ pregnant women with CD4 count < 200 cells/mm3
pdf, 38kb -
Risk-benefit analysis
pdf, 70kb
When to switch ART in HIV+ adults and adolescents
GRADE tables
-
Clinical + immunologic monitoring versus clinical + immunologic + virologic monitoring to guide ART switching in HIV+ adults and adolescents in RLS
pdf, 53kb -
Clinical monitoring versus clinical+ immunologic monitoring to guide ART switching in HIV+ adults and adolescents in RLS
pdf, 43kb -
Clinical monitoring versus clinical+ immunologic + virologic monitoring to guide ART switching in HIV+ adults and adolescents in RLS
pdf, 42kb
-
Risk-benefit analysis
pdf, 55kb -
First-line ART failure and attrition rates in RLS (metanalysis)
pdf, 80kb -
Meeting report: WHO consultation on ART failure in the context of RLS
pdf, 3.87Mb -
Routine versus clinically driven laboratory monitoring of HIV ART in Africa
pdf, 345kb
Second-line ART
GRADE tables
-
Fos-amprenavir/ritonavir versus lopinavir/ritonavir in HIV+ patients failing first-line ART
pdf, 40kb -
3TC maintenance in HIV+ patients failing first-line ART
pdf, 32kb -
Atazanavir/ritonavir versus lopinavir/ritonavir in HIV+ patients failing first-line ART
pdf, 66kb -
Darunavir/ritonavir versus lopinavir/ritonavir in HIV+ patients failing first-line ART
pdf, 40kb -
PI monotherapy in HIV+ failing first-line ART
pdf, 42kb
Third-line ART
-
Recommendations
pdf, 31kb -
Summary of evidence (considerations on use of 3rd line therapy)
pdf, 71kb -
Risk-benefit analysis
pdf, 57kb -
Non-virologic criteria to predict virologic failure in TAHOD and AHOD (article)
pdf, 585kb
HIV care interventions
- Essential prevention and care interventions for adults and adolescents living with HIV in RLS
- WHO guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults (2006)
- Meeting report: Intensified case finding, Isoniazid preventive therapy and TB infection control for people living with HIV
Guiding principles
-
Technical brief on HIV viral load technologies
pdf, 2.25Mb
June 2010 -
Technical brief on CD4 technologies
pdf, 1.38Mb
May 2010 -
Stavudine phase out management
pdf, 51kb -
ART laboratorial monitoring
pdf, 69kb -
Review of CD4 cell count technologies (presentation)
pdf, 565kb